tiprankstipranks
Lexicon price target lowered to $4 from $6 at H.C. Wainwright
PremiumThe FlyLexicon price target lowered to $4 from $6 at H.C. Wainwright
2M ago
Lexicon to eliminate commercial organization, focus on clinical development
Premium
The Fly
Lexicon to eliminate commercial organization, focus on clinical development
2M ago
Lexicon Pharmaceuticals Appoints Ivan Cheung to Board
Premium
Company Announcements
Lexicon Pharmaceuticals Appoints Ivan Cheung to Board
2M ago
Lexicon announces JASN publishes sotagliflozin data
PremiumThe FlyLexicon announces JASN publishes sotagliflozin data
3M ago
Lexicon to present data from two studies related to LX9851
Premium
The Fly
Lexicon to present data from two studies related to LX9851
3M ago
LXRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LXRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Lexicon’s LX9211 progressing ahead of schedule, says H.C. Wainwright
PremiumThe FlyLexicon’s LX9211 progressing ahead of schedule, says H.C. Wainwright
3M ago
Lexicon completes screening in Phase 2B progress study of LX9211
Premium
The Fly
Lexicon completes screening in Phase 2B progress study of LX9211
3M ago
Lexicon signs licensing agreement with Viatris for sotagliflozin
Premium
The Fly
Lexicon signs licensing agreement with Viatris for sotagliflozin
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100